Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Nagel

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Pediatric Blood & Cancer|January 18, 2006
Complementary and alternative medicine in pediatric oncology: availability and institutional policies in Canada--a report from the Children's Oncology GroupDonna L Johnston, Kim Nagel, Claire O'Halloran, et al.
BMC Cancer|July 28, 2012
Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?Jacqueline Halton, Kim Nagel, Leonardo R Brandão, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Pediatric Blood & Cancer|January 18, 2006
Complementary and alternative medicine in pediatric oncology: availability and institutional policies in Canada--a report from the Children's Oncology GroupDonna L Johnston, Kim Nagel, Claire O'Halloran, et al.
BMC Cancer|July 28, 2012
Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?Jacqueline Halton, Kim Nagel, Leonardo R Brandão, et al.
Pageof 3